Findings of large clinical trial may have major implications for treatment of small-cell lung cancer

by SUNY Upstate Medical UniversityCredit: Pixabay/CC0 Public DomainA clinical trial led by Upstate Medical University radiation oncologist Dr. Jeffrey Bogart may have major implications for the treatm

Updated on: December 20,2023 9

Findings of large clinical trial may have major implications for treatment of small-cell lung cancer

by SUNY Upstate Medical UniversityCredit: Pixabay/CC0 Public DomainA clinical trial led by Upstate Medical University radiation oncologist Dr. Jeffrey Bogart may have major implications for the treatm

Updated on:December 20,2023 9

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim

Updated on: December 22,2023 24

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim

Updated on:December 22,2023 24

Why lung cancer doesn't respond well to immunotherapy

by Anne Trafton,Massachusetts Institute of TechnologyA new MIT study explains why dendritic cells (green) in lymph nodes that drain from the lungs fail to stimulate killer T cells (white) to att

Updated on: January 08,2024 10

Why lung cancer doesn't respond well to immunotherapy

by Anne Trafton,Massachusetts Institute of TechnologyA new MIT study explains why dendritic cells (green) in lymph nodes that drain from the lungs fail to stimulate killer T cells (white) to att

Updated on:January 08,2024 10

Vitamin B6, leukemia's deadly addiction

by Brian Stallard,Cold Spring Harbor LaboratoryThe PDXK enzyme manages the activity of B6, activating it when it is time for cells to divide. In AML, cancerous cells (green) can take advantage o

Updated on: December 22,2023 22

Vitamin B6, leukemia's deadly addiction

by Brian Stallard,Cold Spring Harbor LaboratoryThe PDXK enzyme manages the activity of B6, activating it when it is time for cells to divide. In AML, cancerous cells (green) can take advantage o

Updated on:December 22,2023 22

Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

by Roswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to hav

Updated on: December 20,2023 10

Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

by Roswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to hav

Updated on:December 20,2023 10

New clue discovered as to how and why cancer cells spread

by Gillian Rutherford,University of AlbertaViscosity enhances cell migration and promotes an ARP2/3-mediated dense actin network at the leading edge.a,b, Speeds of MDA-MB-231 cells (a) and

Updated on: December 22,2023 16

New clue discovered as to how and why cancer cells spread

by Gillian Rutherford,University of AlbertaViscosity enhances cell migration and promotes an ARP2/3-mediated dense actin network at the leading edge.a,b, Speeds of MDA-MB-231 cells (a) and

Updated on:December 22,2023 16

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w

Updated on: October 12,2023 202

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w

Updated on:October 12,2023 202

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Updated on: December 22,2023 10

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Updated on:December 22,2023 10

Scientists develop powerful AI algorithm to gain new insights into deadly glioblastoma

by Sylvester Comprehensive Cancer CenterThe SPHINKS network for the precision targeting of master kinases in glioblastoma. Credit: Antonio Iavarone, M.D.Scientists at Sylvester Comprehensive Cancer Ce

Updated on: December 27,2023 10

Scientists develop powerful AI algorithm to gain new insights into deadly glioblastoma

by Sylvester Comprehensive Cancer CenterThe SPHINKS network for the precision targeting of master kinases in glioblastoma. Credit: Antonio Iavarone, M.D.Scientists at Sylvester Comprehensive Cancer Ce

Updated on:December 27,2023 10

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Updated on: December 21,2023 21

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Updated on:December 21,2023 21

NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol use

Updated on: December 18,2023 11

NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol use

Updated on:December 18,2023 11

Most persons screened for lung cancer meet USPSTF criteria, but adherence to follow-up screening low

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of more than 1 million people has found that most persons screened for lung cancer meet U.S. Preventative Services

Updated on: December 20,2023 12

Most persons screened for lung cancer meet USPSTF criteria, but adherence to follow-up screening low

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of more than 1 million people has found that most persons screened for lung cancer meet U.S. Preventative Services

Updated on:December 20,2023 12